YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Kabra Drugs
Kabra Drugs
BSE: 524322NSE: ISIN: INE323K01017

9th-Jul-2020 17:26Source: BSE

Kabra Drugs - Mr. B.V. Anatha Kumar Is Authorised To Look For New Premises For Corporate Office At Bangalore And Marketing Office At Chennai.


I am directed to inform that the meeting of the Board of Directors of the Company was held on 9th July, 2020, and following business was transacted, inter alia, at the meeting of the Board of Directors:

1. Mr. B.V. Anatha Kumar is authorised to look for new premises for Corporate office at Bangalore and Marketing office at Chennai.

Kindly acknowledge the receipt and take the same on your record.